STOCK TITAN

Butterfly Network to Present at the Jefferies London Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) will participate at the Jefferies London Healthcare Conference on November 14-16, 2023. CEO Joseph DeVivo and CFO Heather Getz will present on November 14 at 3:30 PM GMT. A live webcast will be available on the Butterfly Network investor website.
Positive
  • None.
Negative
  • None.

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)-- Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will participate at the Jefferies London Healthcare Conference taking place on November 14-16, 2023. Joseph DeVivo, Chief Executive Officer, and Heather Getz, Executive Vice President & Chief Financial Officer, will present on November 14, 2023, at 3:30 PM GMT.

A live webcast of the presentation will be available in the Events & Presentations section of the Butterfly Network investor website.

About Butterfly Network, Inc.

Founded by Dr. Jonathan Rothberg in 2011 and listed on the New York Stock Exchange through a business combination with Longview Acquisition Corp., Butterfly created the world's first handheld, single probe, whole-body ultrasound system using semiconductor technology, the Butterfly iQ+. Butterfly's mission is to democratize medical imaging and contribute to the aspiration of global health equity, making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Through its proprietary Ultrasound-on-Chip™ technology, Butterfly is paving the way for earlier detection and remote management of health conditions around the world. The Butterfly iQ+ can be purchased online today by healthcare practitioners in the United States, Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, New Zealand, Norway, Poland, Portugal, Spain, Sweden, Switzerland, and the United Kingdom.

Butterfly iQ+ is a prescription device intended for trained healthcare professionals only.

Investors

Heather Getz

Chief Financial & Operations Officer

hgetz@butterflynetinc.com



Neal Nagarajan

Sloane & Company

(301) 273-5662

nnagaragan@sloanepr.com

Source: Butterfly Network, Inc.

FAQ

When will Butterfly Network participate at the Jefferies London Healthcare Conference?

Butterfly Network will participate on November 14-16, 2023.

Who will be presenting at the conference?

CEO Joseph DeVivo and CFO Heather Getz will present.

What time will the presentation take place?

The presentation will take place on November 14, 2023, at 3:30 PM GMT.

Where can I watch the presentation?

A live webcast will be available in the Events & Presentations section of the Butterfly Network investor website.

Butterfly Network, Inc.

NYSE:BFLY

BFLY Rankings

BFLY Latest News

BFLY Stock Data

219.14M
152.61M
20.5%
37.34%
10.47%
Irradiation Apparatus Manufacturing
Manufacturing
Link
United States of America
BURLINGTON

About BFLY

butterfly network operates at the cutting edge of multiple engineering and scientific disciplines and strives to bring together world-class talent in computer science, physics, and electrical engineering. the company is privately held and well funded by a small group of extraordinarily successful serial entrepreneurs. the company is in the rare position of being able to focus 100% of its efforts on product and intellectual property development rather than fundraising.